NCT00844623View on ClinicalTrials.gov

TK-based Suicide Gene Therapy for Hepatocellular Carcinoma

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

November 30, 2003

Study Completion Date

March 31, 2008

Conditions
Carcinoma, Hepatocellular
Interventions
GENETIC

TK99UN

escalated dosis from 2x10e10 to 2x10e12 viral particles injected intratumorally

Trial Locations (1)

31008

Clinica Universitaria de Navarra, Pamplona

All Listed Sponsors
lead

Clinica Universidad de Navarra, Universidad de Navarra

OTHER

NCT00844623 - TK-based Suicide Gene Therapy for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter